-
Tata India Pharma & Healthcare Growth
Equity healthcare
Overview ( as on 12/12/25 )
NAV
₹30.43
Last change
₹0.02 +0.0%
Fund Size (AUM)
1338.85 Cr
Performance
15.95% (5Y)
Fund Details
Tata India Pharma & Healthcare Growth
as of 12/12/25
AUM
1338.85 Cr
Expense Ratio
2.1 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K016A9
Fund Manager
Rajat Srivastava
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Growth | -1.03% | 21.85% | 15.95% |
| Nifty Pharma TR INR | 2.79% | 23.3% | 17.18% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
7.75% |
Max Healthcare Institute Ltd Ordinary Shares |
5.65% |
HealthCare Global Enterprises Ltd |
5.13% |
Abbott India Ltd |
5.04% |
Apollo Hospitals Enterprise Ltd |
4.85% |
Ipca Laboratories Ltd |
3.99% |
Cipla Ltd |
3.96% |
Rainbow Childrens Medicare Ltd |
3.78% |
Lupin Ltd |
3.57% |
Ajanta Pharma Ltd |
3.45% |
Sector Allocation
Healthcare |
95.64% |
Basic Materials |
4.36% |
Asset Allocation
-
95%
Equity
-
5%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
15.74% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
15.74% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
15.74% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
17.28% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
17.28% (5Y)
-
-
Tata India Pharma & Healthcare Growth
Equity healthcare-
Returns
-
15.95% (5Y)
-
